Continuous Glucose Monitoring (CGM)
- Small size
GlucoModicum has discovered and developed a new technology which enables needle-free health monitoring. This technology has never been reported earlier and, during the past four years, we have developed it into a consumer product. We have a portfolio of products and solutions of which the accuracy and safety of the technology has been validated in clinical pilots.
The first solution has been created for needle-free glucose monitoring.
Enhanced and miniaturized electronics & functionality for the industrial product (“Flint 2”) has been completed
GlucoModicum has completed one of the key milestones, M1, in reaching the CE mark for the first in-market product (“Flint 2”)
The technology can be miniaturized into smaller-sized form factors such as a ring and a patch. The work and patent portfolio are on-going in order to complete the first prototypes.
Track your glucose levels as needed.
GlucoModicum evaluates and develops solutions to other analytes, in addition to glucose.